BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence
Status:
Completed
Trial end date:
2020-07-02
Target enrollment:
Participant gender:
Summary
Based on the results of the Phase 2 Study 191622-130 [NCT02010775], the current Phase 2b
study is designed to further evaluate the safety and efficacy of BOTOX® for the treatment of
Masseter Muscle Prominence (MMP) in adults.
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A